Setting and patients: 47 patients (aged 40 years or older) who had reversal of sterilisation performed between 1997 and 2005 in Adelaide, South Australia (n = 35), or the Infertility Centre of St Louis, Missouri, USA (n = 12).
Results: Of the 47 patients on whom follow-up was obtainable from the two centres, 19 (40%) had a live birth, 7 had had only a first trimester miscarriage at the time of follow-up, and 21 (44%) had failed to conceive. Age at conception ranged between 40 and 47 years. Two women had two live births following surgery. The total direct costs (Australian dollars, adjusted to 2005) in Australia were $4850 per treatment, and $11 317 per live birth. The corresponding direct cost of a single cycle of in-vitro fertilisation (IVF) in Australia has been estimated at $6940, with a cost per live birth of $97 884 for women aged 40–42 years and $182 794 for older women.
Conclusion: Previously sterilised women wanting further pregnancy should be offered tubal surgery as an alternative to IVF, as it offers them the opportunity to have an entirely natural pregnancy. In settings where IVF is financially supported by government agencies or insurance, tubal reversal is a highly cost-effective strategy for the previously fertile woman.
Sterilisation is common in Australia and the United States, usually chosen at family completion. Requests for renewed fertility arise because of a new partner, improved economic circumstances or, more rarely, death of a child. Current options for renewed fertility include in-vitro fertilisation (IVF) or surgical reanastomosis of the fallopian tubes. There are many financial and clinical implications in the choice of treatment, particularly for women aged 40 years and older. Human fertility decreases markedly at the end of reproductive life, with age-related fecundity declining rapidly after age 40 years, particularly in sub-fertile women. Possibly for this reason, the American Fertility Society recommends that women older than 40 years have IVF and not undergo reversal of sterilisation.1
In Australia, the live birth rate following IVF treatment is 5% for women aged 40–42 years and 2% for older women.2,3 IVF requires intensive treatment by a team of doctors, nurses and counsellors, with each repeat fresh or frozen embryo thaw cycle incurring additional emotional and financial costs. The use of assisted reproductive technology has caused a significant increase in high-risk multiple pregnancies across all ages, which has given impetus for single embryo transfers, with subsequent increase in the number of treatment cycles to achieve success.
For women choosing tubal reanastomosis, markedly different financial circumstances apply. In Australia since 1997, when Medicare payment for reversal of sterilisation was withdrawn, the choice has been to self-fund a reversal operation or to undergo Medicare-funded and “safety net”-supported IVF treatment, for which most of the cost is reimbursed in second and subsequent IVF treatments in the same calendar year. Tubal reanastomosis requires a general anaesthetic and day surgery admission, but offers the prospect of spontaneous pregnancy with a natural background rate of multiple pregnancy of less than 2% and the opportunity to have more than one child before reconsidering contraceptive options. However, the most important difference is the restored capacity for conception with each ovulatory cycle, which may provide an explanation for conception in older women when gonadotrophin-stimulated oocyte development, fertilisation and implantation seem to be no longer successful.
The main factors influencing success following reanastomosis are the site of anastomosis,4-6 length of residual fallopian tube, and the surgical technique.7 For the most commonly encountered Filshie or Hulka Clip and Falope-Ring type of sterilisation, microsurgery offers a very high chance of tubal patency and fertility. Live birth rates of 80%–90% are achievable in women younger than 40 years,8-12 with poorer outcomes in women aged 40 years or older.13-16
Consenting women aged 40 years or older who had tubal reanastomosis between 1997 and 2005 by two microsurgeons (O M P in Australia and S J S in the United States) were asked to provide details of subsequent pregnancies, by postal questionnaire or phone consultation.
The methods of sterilisation were tubal clips (70%), Falope-Ring (23%) and Pomeroy tubal ligation (7%). The reversal procedure involved a 3–5 cm suprapubic incision, into which the uterine fundus and fallopian tubes were manipulated via a transcervical uterine cannula. A two-layer 8-0 nylon microsurgical anastomosis was performed on the exposed new tubal ends. Magnification (10–253) was provided by an OPMI5 Zeiss operating microscope, and tubal patency was confirmed following anastomosis by transcervical instillation of dilute methylene blue dye. Reconstituted tubal lengths were greater than 4 cm in all cases, and the anastomoses were isthmic (85%), tubocornual (5%) and isthmic ampullary (10%). Patients were discharged from hospital within 24 hours of admission.
Of the 47 eligible patients in the Australian group, three could not be found and seven refused enrolment. Two consenting women were excluded as they were using contraception and not attempting to conceive because of an intercurrent illness. Live births and women’s ages at conception are shown in the Box. Of the 35 Australian women, 20 had been pregnant, although six of these had miscarriages. There were 15 live births (two for one couple). In the St Louis group, six of the 12 women had been pregnant and five had six live births. Overall, 19 of the 47 women had at least one live birth (40%), with six conceptions occurring in women aged 44 years or older and conception reported up to age 47 years. Time to conception ranged from 4 weeks to 4 years. No significant surgical complications occurred and no ectopic pregnancies were reported.
The average monetary cost (Australian dollars, adjusted to 2005) to women having this procedure in the private sector in Australia was $4850, and the cost per live birth was $11 317. This compares very favourably with IVF, where the average cost per cycle in Australia in 2002 was $6940, and the cost per live birth was $97 884 for women aged 40–42 years and $182 794 for women aged 42 years or older.3 Similar ratios of cost-effectiveness of tubal reversal compared with IVF apply in the US.
In this study, the reversal group had all been previously fertile, making direct comparison of success rates for women having IVF not possible, as couples having IVF have multifactorial reasons for accessing treatment, including male-factor infertility. However, our observation that reversal of sterilisation provides a good prospect for fertility indicates that conception is more likely to occur in natural ovulatory cycles than in stimulated IVF cycles. It may be significant that six live births in the study group occurred in women aged 44 years or older, an age when the likelihood of live birth from IVF is extremely low. Additional evidence for natural fertility in older women is seen in a study of reversal of vasectomy, in which 61% of female partners older than 40 years conceived.17
A number of publications and editorials have addressed the issue of fertility and ageing. Discussion largely focuses on age-related increase in meiotic non-disjunction, leading to chromosomal aneuploidy, low implantation rates, and a high rate of early pregnancy loss.18-23 In view of the comparison of cost per live birth, we believe Medicare funding for reversal of sterilisation should be reinstated.
Age and conception intervals for women with births after reversal of sterilisation
Received 12 February 2007, accepted 14 June 2007
- 1. Practice Committee of the American Society for Reproductive Medicine. The role of tubal reconstructive surgery in the era of assisted reproductive technologies. Fertil Steril 2006; 86 Suppl 4: S31-S34.
- 2. Wang YA, Dean JH, Grayson N, Sullivan EA. Assisted reproduction technology in Australia and New Zealand 2004. (Assisted Reproduction Technology Series No. 10.) Sydney: AIHW National Perinatal Statistics Unit, 2006. (AIHW Cat. No. PER 39.)
- 3. Chambers GM, Ho MT, Sullivan EA. Assisted reproductive technology treatment costs of a live birth: an age stratified cost-outcome study of treatment in Australia. Med J Aust 2006; 184: 155-158. <MJA full text>
- 4. Gomel VM. Microsurgery in gynaecology. In: Silber SJ, editor. Microsurgery. Baltimore: Williams & Wilkins, 1978.
- 5. Winston R. Tubal anastomosis for reversal sterilization in 45 women. In: Brosens I, Winston R, editor. Reversibility of female sterilization. London: London Academic Press, 1978.
- 6. Silber S, Cohen R. Microsurgical reversal of tubal sterilization: factors affecting pregnancy rate, with long term follow up. Obstet Gynecol 1984; 64: 679-682.
- 7. Hedon B, Wineman M, Winston RM. Loupes or microscope for tubal anastomosis? An experimental study. Fertil Steril 1980; 34: 264-268.
- 8. Wahab MA, Li TC, Cooke ID. Reversal of sterilisation vs. IVF: a cost–benefit analysis. J Obstet Gynaecol 1997; 17: 180-185.
- 9. Kim J-D, Kim K-S, Doo J-K, Rhyeu C-H. A report on 387 women of microsurgical tubal reversals. Fertil Steril 1997; 68: 875-880.
- 10. Petrucco O, Kerin JF, Broom TJ, et al. Ageing and fertility. J Psychosom Obstet Gynaecol 1985; 47: 347-353.
- 11. Magdi M, Hanafi MM. Factors affecting the pregnancy rate after microsurgical reversal of tubal ligation. Fertil Steril 2003; 80: 434-440.
- 12. Petrucco O. Daycare microsurgery on IVF — options for post sterilization fertility. Proceedings of the 11th World Congress on IVF and Human Reproductive Genetics; 1999 May 9–14; Sydney.
- 13. Trimbos-Kemper T. Reversal of sterilization in women over 40 years of age: a multicentre survey in the Netherlands. Fertil Steril 1990; 53: 575-577.
- 14. Dubuisson JB, Chapron C, Nos C, et al. Sterilization reversal: fertility results. Hum Reprod 1995; 10: 1145-1151.
- 15. Glock J, Kim AH, Hulka JF, et al. Reproductive outcome after tubal reversal in women 40 years of age or older. Fertil Steril 1996; 65: 863-865.
- 16. Cohen M, Chang PL, Uhler M, et al. Reproductive outcome after sterilization reversal in women of advanced reproductive age. J Assist Reprod Genet 1999; 16: 402-404.
- 17. Silber S, Grotjan HE. Microscopic vasectomy reversal 30 years later: a summary of 4010 cases by the same surgeon. J Androl 2004; 25: 845-859.
- 18. Gosden R, Rutherford A. Delayed child-bearing [editorial]. BMJ 1995; 311: 1585-1586.
- 19. te Velde E, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002; 8: 141-154.
- 20. Pal L, Santoro N. Age-related decline in fertility. Endocrinol Metab Clin North Am 2003; 32: 669-688.
- 21. Practice Committee of the American Society for Reproductive Medicine. Ageing and infertility in women. Fertil Steril 2004; 82 Suppl 1: S102-S106.
- 22. Lim A, Tsakok MFH. Age related decline in fertility: a link to degenerative oocytes. Fertil Steril 1997; 68: 265-271.
- 23. ESHRE Capri Workshop Group. Fertility and ageing. Hum Reprod Update 2005; 11: 261-276.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.